Results 11 to 20 of about 203,949 (268)

Cisplatin induced paroxysmal supraventricular tachycardia

open access: yesIndian Journal of Medical and Paediatric Oncology, 2013
Cisplatin or cis-diamminedichloroplatinum (CDDP) is the first member of a class of platinum-containing anti-cancer drugs that act by binding to and causing cross-linking of deoxyribonucleic acid, which ultimately triggers apoptosis. Cisplatin has a broad-
Waseem Raja   +4 more
doaj   +2 more sources

PAROXYSMAL TACHYCARDIA IN CHILDREN [PDF]

open access: yesThe American Journal of the Medical Sciences, 1917
n ...
H. Koplik
openaire   +3 more sources

Paroxysmal Supraventricular Tachycardia and Cardiac Arrest: A Presentation of Pulmonary Embolism With Infarction as a Sequela of Long COVID Syndrome

open access: yesCureus, 2021
With the emergence of diverse post-COVID sequelae, there have been reports of thromboembolic events such as stroke, myocardial infarction, and pulmonary embolism. These events have been reported after severe coronavirus disease 2019 (COVID-19) infections
D. Talwar   +4 more
semanticscholar   +1 more source

In The Line of Treatment: A Systematic Review of Paroxysmal Supraventricular Tachycardia

open access: yesCureus, 2021
Paroxysmal supraventricular tachycardia (PSVT) is a common tachyarrhythmia, and an electrocardiogram is the best tool for making a diagnosis. If Valsalva maneuvers and carotid sinus massage do not give positive results, then the next choice is either ...
Farrukh Ahmad   +7 more
semanticscholar   +1 more source

Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation

open access: yesEuropace, 2021
Aims Treatment guidelines for patients with atrial fibrillation (AF) suggest that patients should be managed with an antiarrhythmic drug (AAD) before undergoing catheter ablation (CA).
M. Kuniss   +17 more
semanticscholar   +1 more source

Clinical presentation of paroxysmal supraventricular tachycardia: evaluation of usual and unusual symptoms

open access: yesCardiovascular endocrinology & metabolism, 2020
Objective Clinical presentation of paroxysmal supraventricular tachycardia may vary from asymptomatic occurrence or mild perception of palpitation to severe chest pain or syncope.
E. Yetkın   +3 more
semanticscholar   +1 more source

Intra-Operative Lidocaine Management in the Setting of Ventricular Tachycardia Storm: A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Effective management of VT storm during catheter ablation involves discontinuation of antiarrhythmic agents to facilitate VT induction for mapping of the critical isthmus. Lidocaine is an ideal agent since arrhythmias remain inducible after its discontinuation.
Williams C   +4 more
europepmc   +2 more sources

Vagal Techniques for Terminating Paroxysmal Tachycardia in Children: Assessment of Clinical Electrophysiological Factors of Valsalva Test Effectiveness

open access: yesПедиатрическая фармакология, 2016
Background: Vagal techniques constitute the first line of medical care for terminating paroxysmal supraventricular tachycardia in children and adults due to ease of application, relative safety and possibility of avoiding injection of antiarrhythmic ...
T. K. Kruchina   +2 more
doaj   +1 more source

One symptom, two arrhythmias: the rare and the even rarer

open access: yesBMC Cardiovascular Disorders, 2017
Background Wolff-Parkinson-White (WPW) syndrome and idiopathic left ventricular tachycardia (ILVT) are rare and up to now the coexistence of both entities has rarely been reported.
Florian Zauner   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy